Sign in

Publications

Search in 13050 publications:

Reset RSS
Time frame
13050 Publication(s)
Aug 1, 2022
EJVES Facing a Number of Challenges, but Well Prepared for the Future - Just Like the ESVS!
Dick F, Björck M, Gargiulo M. EJVES Facing a Number of Challenges, but Well Prepared for the Future - Just Like the ESVS!. Eur J Vasc Endovasc Surg 2022; 64:147-149.
Aug 1, 2022
EJVES Facing a Number of Challenges, but Well Prepared for the Future - Just Like the ESVS!
Aug 1, 2022

Eur J Vasc Endovasc Surg 2022; 64:147-149

Dick Florian, Björck Martin, Gargiulo Mauro

more
Aug 1, 2022
Neurosurgery resident training using blended learning concepts: course development and participant evaluation.
Hickmann A, Ferrari A, Bozinov O, Stienen M, Ostendorp C. Neurosurgery resident training using blended learning concepts: course development and participant evaluation. Neurosurg Focus 2022; 53:E13.
Aug 1, 2022
Neurosurgery resident training using blended learning concepts: course development and participant evaluation.
Aug 1, 2022

Neurosurg Focus 2022; 53:E13

Hickmann Anne-Katrin, Ferrari Andrea, Bozinov Oliver, Stienen Martin N, Ostendorp Carsten

more
Aug 1, 2022
Caffeine for intestinal transit after laparoscopic colectomy: randomized clinical trial (CaCo trial)
Abbassi F, Müller S, Steffen T, Schmied B, Warschkow R, Beutner U, Tarantino I. Caffeine for intestinal transit after laparoscopic colectomy: randomized clinical trial (CaCo trial). Br J Surg 2022; 109:1216-1223.
Aug 1, 2022
Caffeine for intestinal transit after laparoscopic colectomy: randomized clinical trial (CaCo trial)
Aug 1, 2022

Br J Surg 2022; 109:1216-1223

Abbassi Fariba, Müller Sascha A, Steffen Thomas, Schmied Bruno, Warschkow Rene, Beutner Ulrich, Tarantino Ignazio

more
Aug 1, 2022
[Please Don't Forget the Neurogenic Thoracic Outlet Syndrome].
Weiss K, Grünert J, Knechtle B. [Please Don't Forget the Neurogenic Thoracic Outlet Syndrome]. Praxis (Bern 1994) 2022; 111:632-638.
Aug 1, 2022
[Please Don't Forget the Neurogenic Thoracic Outlet Syndrome].
Aug 1, 2022

Praxis (Bern 1994) 2022; 111:632-638

Weiss Katja, Grünert Jörg, Knechtle Beat

more
Aug 1, 2022
Stability of Drugs Stored in Helicopters for Use by Emergency Medical Services: A Prospective Observational Study.
Pietsch U, Moeckel J, Koppenberg J, Josi D, Jungwirth A, Hautz W, Wenzel V, Strecke S, Albrecht R. Stability of Drugs Stored in Helicopters for Use by Emergency Medical Services: A Prospective Observational Study. Ann Emerg Med 2022; 80:364-370.
Aug 1, 2022
Stability of Drugs Stored in Helicopters for Use by Emergency Medical Services: A Prospective Observational Study.
Aug 1, 2022

Ann Emerg Med 2022; 80:364-370

Pietsch Urs, Moeckel Johannes, Koppenberg Joachim, Josi Dario, Jungwirth Arne, Hautz Wolf E, Wenzel Volker, Strecke Stephan, Albrecht Roland

more
Jul 28, 2022
Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial.
Meinel T, Kaesmacher J, Buetikofer L, Strbian D, Eker O, Cognard C, Mordasini P, Deppeler S, Mendes Pereira V, Albucher J, Darcourt J, Bourcier R, Guillon B, Papagiannaki C, Costentin G, Sibolt G, Räty S, Gory B, Richard S, Liman J, Ernst M, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Weisenburger-Lile D, Requena M, Garcia-Tornel A, Saleme S, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Boix M, Pop R, Della Schiava L, Luft A, Piotin M, Gentric J, Pikula A, Pfeilschifter W, Arnold M, Siddiqui A, Froehler M, Furlan A, Chapot R, Wiesmann M, Machi P, Diener H, Kulcsar Z, Bonati L, Bassetti C, Escalard S, Liebeskind D, Saver J, Fischer U, Gralla J, SWIFT-DIRECT investigators. Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial. J Neurointerv Surg 2022; 15:e102-e110.
Jul 28, 2022
Time to treatment with bridging intravenous alteplase before endovascular treatment:subanalysis of the randomized controlled SWIFT-DIRECT trial.
Jul 28, 2022

J Neurointerv Surg 2022; 15:e102-e110

Meinel Thomas Raphael, Kaesmacher Johannes, Buetikofer Lukas, Strbian Daniel, Eker Omer Faruk, Cognard Christophe, Mordasini Pasquale, Deppeler Sandro, Mendes Pereira Vitor, Albucher Jean François, Darcourt Jean, Bourcier Romain, Guillon Benoit, Papagiannaki Chrysanthi, Costentin Guillaume, Sibolt Gerli, Räty Silja, Gory Benjamin, Richard Sébastien, Liman Jan, Ernst Marielle Sophie, Boulanger Marion, Barbier Charlotte, Mechtouff Laura, Zhang Liqun, Marnat Gaultier, Sibon Igor, Nikoubashman Omid, Reich Arno, Consoli Arturo, Weisenburger-Lile David, Requena Manuel, Garcia-Tornel Alvaro, Saleme Suzana, Moulin Solène, Pagano Paolo, Saliou Guillaume, Carrera Emmanuel, Janot Kevin, Boix Marti, Pop Raoul, Della Schiava Lucie, Luft Andreas R, Piotin Michel, Gentric Jean-Christophe, Pikula Aleksandra, Pfeilschifter Waltraud, Arnold Marcel, Siddiqui Adnan, Froehler Michael T, Furlan Anthony J, Chapot René, Wiesmann Martin, Machi Paolo, Diener Hans-Christoph, Kulcsar Zsolt, Bonati Leo H, Bassetti Claudio L, Escalard Simon, Liebeskind David S, Saver Jeffrey L, Fischer Urs, Gralla Jan, SWIFT-DIRECT investigators

more
Jul 26, 2022
Forgiveness and Reconciliation
Renz M. Forgiveness and Reconciliation - Initiating Individuation and Enabling Liberation. Routledge, ‎Taylor & Francis Ltd, 2022. ISBN 9781032316970.
Jul 26, 2022
Forgiveness and Reconciliation
Jul 26, 2022

Routledge, ‎Taylor & Francis Ltd, ISBN 9781032316970

Renz Monika

more
Jul 26, 2022
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
Eugster P, Brown N, Hubers S, Schütze I, Reul A, Nölting S, Beuschlein F, Sigrist S, Bilz S, Kolb W, Henzen C, Fischli S, Trepp R, Wuerzner G, Matter M, Abid K, Vocat C, Maurer J, Grouzmann E. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. Clin Chim Acta 2022; 534:146-155.
Jul 26, 2022
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma
Jul 26, 2022

Clin Chim Acta 2022; 534:146-155

Eugster Philippe J, Brown Nancy J, Hubers Scott A, Schütze Ina, Reul Astrid, Nölting Svenja, Beuschlein Felix, Sigrist Sarah, Bilz Stefan, Kolb Walter, Henzen Christoph, Fischli Stefan, Trepp Roman, Wuerzner Gregoire, Matter Maurice, Abid Karim, Vocat Céline, Maurer Jonathan, Grouzmann Eric

more
Jul 26, 2022
Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Christ E, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, Brändle M. Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology. Swiss Med Wkly 2022; 152:w30197.
Jul 26, 2022
Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Jul 26, 2022

Swiss Med Wkly 2022; 152:w30197

Christ Emanuel, Czock Astrid, Renström Frida, Ammeter Tamara, Ebrahimi Fahim, Zechmann Stefan, Kutz Alexander, Diem Peter, Häuptle Christian, Brändle Michael

more
Jul 23, 2022
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).
Schmulenson E, Bovet C, Theurillat R, Decosterd L, Largiadèr C, Prost J, Csajka C, Bärtschi D, Guckenberger M, von Moos R, Bastian S, Jörger M, Jaehde U. Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP). Br J Clin Pharmacol 2022; 88:5336-5347.
Jul 23, 2022
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).
Jul 23, 2022

Br J Clin Pharmacol 2022; 88:5336-5347

Schmulenson Eduard, Bovet Cédric, Theurillat Regula, Decosterd Laurent Arthur, Largiadèr Carlo R, Prost Jean-Christophe, Csajka Chantal, Bärtschi Daniela, Guckenberger Matthias, von Moos Roger, Bastian Sara, Jörger Markus, Jaehde Ulrich

more
Jul 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Janssen J, Löwenberg B, Manz M, Biemond B, Westerweel P, Klein S, Fehr M, Sinnige H, Efthymiou A, Legdeur M, Pabst T, Gregor M, van der Poel M, Deeren D, Tick L, Jongen-Lavrencic M, van Obbergh F, Boersma R, de Weerdt O, Chalandon Y, Heim D, Spertini O, van Sluis G, Graux C, Stüssi G, van Norden Y, Ossenkoppele G. Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome. Leukemia 2022; 36:2189-2195.
Jul 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.
Jul 22, 2022

Leukemia 2022; 36:2189-2195

Janssen J J W M, Löwenberg Bob, Manz M, Biemond B J, Westerweel P E, Klein S K, Fehr M, Sinnige H A M, Efthymiou Anna, Legdeur M C J C, Pabst T, Gregor M, van der Poel M W M, Deeren Dries, Tick L W, Jongen-Lavrencic Mojca, van Obbergh F, Boersma R S, de Weerdt Okke, Chalandon Yves, Heim D, Spertini Olivier, van Sluis G, Graux Carlos, Stüssi G, van Norden Y, Ossenkoppele G J

more
Jul 22, 2022
The percutaneous learning curve of 3rd generation minimally-invasive Chevron and Akin osteotomy (MICA).
Toepfer A, Strässle M. The percutaneous learning curve of 3rd generation minimally-invasive Chevron and Akin osteotomy (MICA). Foot Ankle Surg 2022; 28:1389-1398.
Jul 22, 2022
The percutaneous learning curve of 3rd generation minimally-invasive Chevron and Akin osteotomy (MICA).
Jul 22, 2022

Foot Ankle Surg 2022; 28:1389-1398

Toepfer Andreas, Strässle Michael

more
Jul 22, 2022
Temporizing cast immobilization is a safe alternative to external fixation in ankle fracture-dislocation while posterior malleolar fragment size predicts loss of reduction: a case control study.
Gerlach R, Toepfer A, Jacxsens M, Zdravkovic V, Potocnik P. Temporizing cast immobilization is a safe alternative to external fixation in ankle fracture-dislocation while posterior malleolar fragment size predicts loss of reduction: a case control study. BMC Musculoskelet Disord 2022; 23:698.
Jul 22, 2022
Temporizing cast immobilization is a safe alternative to external fixation in ankle fracture-dislocation while posterior malleolar fragment size predicts loss of reduction: a case control study.
Jul 22, 2022

BMC Musculoskelet Disord 2022; 23:698

Gerlach Rene, Toepfer Andreas, Jacxsens Matthijs, Zdravkovic Vilijam, Potocnik Primoz

more
Jul 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.
Belgers V, Röttgering J, Douw L, Klein M, Ket J, van de Ven P, Würdinger T, van Linde M, Niers J, Weber M, Olde Rikkert M, Lopez-Sendon J, Arrieta O, Svendsen K, Chagas M, de Almeida C, Kouwenhoven M, de Witt Hamer P. Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis. Cannabis Cannabinoid Res 2022; 8:41-55.
Jul 21, 2022
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.
Jul 21, 2022

Cannabis Cannabinoid Res 2022; 8:41-55

Belgers Vera, Röttgering Jantine G, Douw Linda, Klein Martin, Ket Johannes C F, van de Ven Peter M, Würdinger Thomas, van Linde Myra E, Niers Johanna M, Weber Markus, Olde Rikkert Marcel G, Lopez-Sendon Jose, Arrieta Oscar, Svendsen Kristina B, Chagas Marcos H N, de Almeida Carlos M O, Kouwenhoven Mathilde C M, de Witt Hamer Philip C

more
Jul 21, 2022
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms.
Haberecker M, Bühler M, Mendieta A, Guggenberger R, Arnold F, Markert E, Rechsteiner M, Zoche M, Britschgi C, Pauli C. Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms. Mod Pathol 2022; 35:1860-1869.
Jul 21, 2022
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms.
Jul 21, 2022

Mod Pathol 2022; 35:1860-1869

Haberecker Martina, Bühler Marco Matteo, Mendieta Alicia Pliego, Guggenberger Roman, Arnold Fabian, Markert Eva, Rechsteiner Markus, Zoche Martin, Britschgi Christian, Pauli Chantal

more
Jul 21, 2022
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.
Rovó A, Baierlein-Leimbach C, Medri C, Chanias I, Errass L, Fehr T, Triemer T, McCarthy-Pontier D, Lehmann T. Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice. J Clin Med 2022; 11
Jul 21, 2022
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.
Jul 21, 2022

J Clin Med 2022; 11

Rovó Alicia, Baierlein-Leimbach Claudia, Medri Cesare, Chanias Ioannis, Errass Loreen, Fehr Theresa, Triemer Therese, McCarthy-Pontier Daphne B, Lehmann Thomas

more
Jul 21, 2022
In-hospital survival paradox in patients with sleep apnea-A nation-wide nested case-control study.
Moser M, Baty F, Brutsche M, Schoch O. In-hospital survival paradox in patients with sleep apnea-A nation-wide nested case-control study. PloS one 2022; 17:e0271004.
Jul 21, 2022
In-hospital survival paradox in patients with sleep apnea-A nation-wide nested case-control study.
Jul 21, 2022

PloS one 2022; 17:e0271004

Moser Maurice, Baty Florent, Brutsche Martin H, Schoch Otto D

more
Jul 20, 2022
Expanding the indications for measurement of objective functional impairment in spine surgery: A pilot study of four patients with diseases affecting the spinal cord.
Fischer G, Kälin V, Gautschi O, Bozinov O, Stienen M. Expanding the indications for measurement of objective functional impairment in spine surgery: A pilot study of four patients with diseases affecting the spinal cord. Brain Spine 2022; 2:100915.
Jul 20, 2022
Expanding the indications for measurement of objective functional impairment in spine surgery: A pilot study of four patients with diseases affecting the spinal cord.
Jul 20, 2022

Brain Spine 2022; 2:100915

Fischer Gregor, Kälin Vincens, Gautschi Oliver P, Bozinov Oliver, Stienen Martin N

more
Jul 18, 2022
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.
Ferguson I, Lin Y, Lam C, Shao H, Tharp K, Hale M, Kasap C, Mariano M, Kishishita A, Patiño Escobar B, Mandal K, Steri V, Wang D, Phojanakong P, Tuomivaara S, Hann B, Driessen C, Van Ness B, Gestwicki J, Wiita A. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma. Cell Chem Biol 2022; 29:1288-1302.e7.
Jul 18, 2022
Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.
Jul 18, 2022

Cell Chem Biol 2022; 29:1288-1302.e7

Ferguson Ian D, Lin Yu-Hsiu T, Lam Christine, Shao Hao, Tharp Kevin M, Hale Martina, Kasap Corynn, Mariano Margarette C, Kishishita Audrey, Patiño Escobar Bonell, Mandal Kamal, Steri Veronica, Wang Donghui, Phojanakong Paul, Tuomivaara Sami T, Hann Byron, Driessen Christoph, Van Ness Brian, Gestwicki Jason E, Wiita Arun P

more
Jul 18, 2022
The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Akeret K, Buzzi R, Saxenhofer M, Bieri K, Chiavi D, Thomson B, Grüttner-Durmaz M, Schwendinger N, Humar R, Regli L, van Doormaal T, Held U, Keller E, Hugelshofer M, Schaer D, Hostettler I. The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury. BMC Neurol 2022; 22:267.
Jul 18, 2022
The HeMoVal study protocol: a prospective international multicenter cohort study to validate cerebrospinal fluid hemoglobin as a monitoring biomarker for aneurysmal subarachnoid hemorrhage related secondary brain injury.
Jul 18, 2022

BMC Neurol 2022; 22:267

Akeret Kevin, Buzzi Raphael, Saxenhofer Moritz, Bieri Kathrin, Chiavi Deborah, Thomson Bart R, Grüttner-Durmaz Manuela, Schwendinger Nina, Humar Rok, Regli Luca, van Doormaal Tristan P C, Held Ulrike, Keller Emanuela, Hugelshofer Michael, Schaer Dominik J, Hostettler Isabel C

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy